RAM
TEVA icon

Redmond Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Redmond Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-87,347
Closed -$657K – 184
2022
Q2 		$657K Sell
87,347
-11,513
-12% -$100K 0.24% 129
2022
Q1 		$928K Sell
98,860
-5,194
-5% -$43.3K 0.28% 126
2021
Q4 		$833K Sell
104,054
-18,784
-15% -$170K 0.23% 133
2021
Q3 		$1.2M Buy
122,838
+822
+0.7% +$7.7K 0.37% 87
2021
Q2 		$1.21M Buy
+122,016
New +$1.29M 0.35% 93

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Redmond Asset Management's TEVA Position: Q3 2022 in Review

Redmond Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 87,347 shares — an estimated $657K sold.

Redmond Asset Management first reported a position in TEVA in Q2 2021 and held it in 5 quarters. The position peaked at $1.21M in Q2 2021. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Redmond Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Redmond Asset Management sold 87,347 Teva Pharmaceuticals shares in Q3 2022, an estimated $657K.
  • Redmond Asset Management first reported a position in Teva Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Redmond Asset Management's Teva Pharmaceuticals position peaked at $1.21M in Q2 2021.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Redmond Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.